Company / Inventory
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$49.3M
FY2025
5-year range
$24.6M / $58.8M
FY2021-FY2025
Trend
-16.1%
vs FY2024
Sector context
#88 of 115
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s inventory of $49M is lower than 77% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 10 years, ranging from $13M in FY2019 to $59M in FY2024.
Based on SEC 10-K filings.
$49M in FY2025 with a 5-year CAGR of +28.2%.
Declined from $57M to $49M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -0.7%
- 5-Year CAGR
- +28.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 115This company $49.3M Sector average $1.4B
▼
-96.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +28.2%, indicating consistent growth.
- In FY2025, inventory decreased 16.1% year-over-year.
- Ranks #88 out of 115 companies in the Health Care sector.
- Peak inventory was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $49.3M | -16.1% |
| FY2024 | $58.8M | +3.7% |
| FY2023 | $56.7M | +12.5% |
| FY2022 | $50.4M | +104.8% |
| FY2021 | $24.6M | +72.9% |
| FY2020 | $14.2M | +6.9% |
| FY2019 | $13.3M | -25.5% |
| FY2018 | $17.9M | -22.5% |
| FY2017 | $23.1M | +47.5% |
| FY2016 | $15.6M | +42.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026